AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
TL;DR
This chapter illustrates how EV-focused proteomics enables the systematic dissection of microenvironment-driven oncogenic signaling and provides a translational framework for discovering actionable stromal targets in CLL and other Lyn-dependent malignancies.
It is suggested that the differential loading of translational machinery into the extracellular space─likely via microvesicles or coisolated nonvesicular particles─contributes to poor prognosis, offering new insights into the systemic secretome of aggressive tumors.
These findings provide the first comprehensive molecular characterization of EVs released by MCPyV-positive MCC cells and establish a foundation for investigating the contribution of EV-mediated communication to MCC biology and tumor–microenvironment interactions.
Integrated multi-omic profiling of human tumor-infiltrating T cells reveals cell-intrinsic regulators of T cell dysfunction that are missed by transcriptomic analyses alone, highlighting an additional layer of regulatory control.
ThyTreg-derived EVs are identified as a novel, cell-free platform with potential for immunomodulatory therapies and a defined molecular cargo.
Hypoxia alters phosphatidylserine organization in tumor-derived sEVs, enhancing ADAM17 activation, promoting PS-dependent CD8+ T-cell apoptosis, and facilitating immune evasion in HNSCC.
A comprehensive and systematic overview of EVs in TC is provided, with particular emphasis on methodological factors influencing EV research, including sample-specific isolation and characterization strategies, and critically evaluating methodological challenges and outlining future directions for clinical translation.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.